REN and melanoma: Our findings provide suggestive evidence that genetic liability to the use of certain medications—particularly agents acting on the renin–angiotensin system, diuretics, thyroid preparations, and diabetes drugs in the FinnGen dataset and adrenergics, inhalants, glucocorticoids, and opioids in the UK Biobank dataset—may be associated with melanoma risk.